1. Home
  2. QUIK vs HBIO Comparison

QUIK vs HBIO Comparison

Compare QUIK & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$20.39

Market Cap

211.8M

Sector

Technology

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$5.34

Market Cap

24.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
HBIO
Founded
1988
1901
Country
United States
United States
Employees
51
339
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
24.9M
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
QUIK
HBIO
Price
$20.39
$5.34
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$11.00
$18.00
AVG Volume (30 Days)
767.4K
28.2K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,112,000.00
$116,176,000.00
Revenue This Year
$75.17
$4.77
Revenue Next Year
$16.04
$8.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$0.28
52 Week High
$22.69
$7.50

Technical Indicators

Market Signals
Indicator
QUIK
HBIO
Relative Strength Index (RSI) 63.20 43.85
Support Level $5.83 $4.42
Resistance Level N/A $5.79
Average True Range (ATR) 2.07 0.43
MACD -0.13 -0.26
Stochastic Oscillator 71.21 15.02

Price Performance

Historical Comparison
QUIK
HBIO

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: